Stock Analysis

GoHealth Full Year 2022 Earnings: Misses Expectations

Source: Shutterstock

GoHealth (NASDAQ:GOCO) Full Year 2022 Results

Key Financial Results

  • Revenue: US$631.7m (down 41% from FY 2021).
  • Net loss: US$148.7m (loss narrowed by 22% from FY 2021).
  • US$17.61 loss per share (improved from US$26.80 loss in FY 2021).
NasdaqCM:GOCO Earnings and Revenue Growth March 18th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

GoHealth Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 31%. Earnings per share (EPS) also missed analyst estimates significantly.

Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Insurance industry in the US.

Performance of the American Insurance industry.

The company's shares are down 24% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 3 warning signs for GoHealth that you should be aware of.

What are the risks and opportunities for GoHealth?

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States.

View Full Analysis


  • Revenue is forecast to grow 15.21% per year


  • Shareholders have been diluted in the past year

  • Volatile share price over the past 3 months

  • Currently unprofitable and not forecast to become profitable over the next 3 years

View all Risks and Rewards

Share Price

Market Cap

1Y Return

View Company Report